Is consensus in anti-aging medical intervention an elusive expectation or a realistic goal?

Archives of Gerontology and Geriatrics

Volumn 48, Issue 3, 2009, Pages 271-275

  Zs Nagy, Imre ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adult growth hormone deficiency (AGHD) syndrome; Anti aging medical interventions; Human growth hormone (hGH); The membrane hypothesis of aging (MHA); Theoretical basis of the hGH replacement therapy

Indexed keywords

HUMAN GROWTH HORMONE;

AGING; ANTIAGING MEDICAL INTERVENTION; EDITORIAL; GERONTOLOGIST; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; INTERVENTION STUDY; MEDICAL PROFESSION; MEDICAL RESEARCH; PRIORITY JOURNAL; THEORETICAL STUDY;

AGING; CELL MEMBRANE; CONSENSUS; GOALS; HUMAN GROWTH HORMONE; HUMANS; LONGEVITY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 62949102814     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.02.002     Document Type: Editorial

References (29)

1. Bates A.S., Van't Hoff W., Jones P.J., and Clayton R.N. The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. 81 (1996) 1169-1172
2. Bengtsson B.A., Koppeschaar H.P., Abs R., Bennmarker H., Hernberg-Ståhl E., Westberg B., Wilton P., Monson J.P., Feldt-Rasmussen U., and Wüster C. Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group. J. Clin. Endocrinol. Metab. 84 (1999) 4291-4292
3. Birkhäuser M.H., and Reinecke I. Current trends in hormone replacement therapy: perceptions and usage. Climacteric 11 (2008) 192-200
4. Canderelli R., Leccesse L.A., Miller N.L., and Unruh Davidson J. Benefits of hormone replacement therapy in postmenopausal women. J. Am. Acad. Nurse Pract. 19 (2007) 635-641
5. Christmas C., O'Connor K.G., Harman S.M., Tobin J.D., Münzer T., Bellan-toni M.F., Clair C.S., Pabst K.M., Sorkin J.D., and Blackman M.R. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J. Gerontol. A: Biol. Sci. Med. Sci. 57 (2002) M12-M18
6. Hernberg-Ståhl E., Luger A., Abs R., Bengtsson B.A., Feldt-Rasmussen U., Wilton P., Westberg B., Monson J.P., KIMS International Board, and KIMS Study Group. Pharmacia International Metabolic Database. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J. Clin. Endocrinol. Metab. 86 (2001) 5277-5281
7. Khansari D.N., and Gustad T. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech. Ageing Dev. 57 (1991) 87-100
8. Pape G.S., Friedman M., Underwood L.E., and Clemmons D.R. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 99 (1991) 1495-1500
9. Perls T.T., Reisman R.R., and Olshansky S.J. Provision or distribution of growth hormone for "antiaging": clinical and legal issues. J. Am. Med. Assoc. 294 (2005) 2086-2090
10. Press Releases of NIA, 1998. First Emmy for government public service announcements (PSA). Available from:
11. Rosén T., and Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336 (1990) 285-288
12. Snel Y.E., Doerga M.E., Brummer R.J., Zelissen P.M., Zonderland M.L., and Koppeschaar H.P. Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy. Eur. J. Endocrinol. 133 (1995) 445-450
13. Sonntag W.E., Carter C.S., Ikeno Y., Ekenstedt K., Carlson C.S., Loeser R.F., Chakrabarty S., Lee S., Bennett C., Ingram R., Moore T., and Ramsey M. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146 (2005) 2920-2932
14. Strehler B.L. Origin and comparison of the effects of time and high energy radiations on living systems. Quart. Rev. Biol. 34 (1959) 117-142
15. Svensson J., Bengtsson B.A., Rosén T., Odén A., and Johannsson G. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J. Clin. Endocrinol. Metab. 89 (2004) 3306-3312
16. Swerdlow A.J., Reddingius R.E., Higgins C.D., Spoudeas H.A., Phipps K., Qiao Z., Ryder W.D., Brada M., Hayward R.D., Brook C.G., Hindmarsh P.C., and Shalet S.M. Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J. Clin. Endocrinol. Metab. 85 (2000) 4444-4449
17. Tacke J., Bolder U., Herrmann A., Berger G., and Jauch K.W. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone. J. Parenter. Enteral. Nutr. 24 (2000) 140-144
18. Toogood A. Safety and efficacy of growth hormone replacement therapy in adults. Expert Opin. Drug Saf. 4 (2005) 1069-1082
19. Welle S., Thornton C., Statt M., and McHenry B. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. J. Clin. Endocrinol. Metab. 81 (1996) 3239-3243
20. Welton A.J., Vickers M.R., Kim J., Ford D., Lawton B.A., MacLennan A.H., Meredith S.K., Martin J., Meade T.W., and WISDOM Team. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. Brit. Med. J. 337 (2008) a1190
21. Wüster C., Melchinger U., Eversmann T., Hensen J., Kann P., Von zur Mühlen A., Ranke M.B., Schmeil H., Steinkamp H., and Tuschy U. Reduced incidence of side-effects of growth hormone substitution in 404 patients with hypophyseal insufficiency. Results of a multicenter indications study. Med. Klin. (Munich) 93 (1998) 585-591 (in German)
22. Zs.-Nagy I. A membrane hypothesis of aging. J. Theor. Biol. 75 (1978) 189-195
23. Zs.-Nagy I. The role of membrane structure and function in cellular aging: a review. Mech. Ageing Dev. 9 (1979) 237-246
24. Zs.-Nagy I. A proposal for reconsideration of the role of oxygen free radicals in cell differentiation and aging. Ann. N. Y. Acad. Sci. 673 (1992) 142-148
25. Zs.-Nagy I. The Membrane Hypothesis of Aging (1994), CRC Press, Inc., Boca Raton, FL 207 pp.
26. Zs.-Nagy I. Semiconduction of proteins as an attribute of the living state: The ideas of Albert Szent-Györgyi revisited in the light of the recent knowledge regarding oxygen free radicals. Exp. Gerontol. 30 (1995) 327-335
27. Zs.-Nagy I. The membrane hypothesis of aging: its relevance to recent progress in genetic research. J. Mol. Med. 75 (1997) 703-714
28. Zs.-Nagy I. Is there any outcome from the deadlock of the gerontological theories?. Magyar Belorv. Arch. 57 (2004) 112-116 (in Hungarian)
29. Zs.-Nagy I. May become the human growth hormone (hGH) replacement therapy a useful anti-aging intervention? An open-minded theoretical approach. In: Sinigoj G., Hirokawa K., Jones G., and Linhart S. (Eds). The Impact of Ageing: A Common Challenge for Europe and Asia (2007), LIT Publisher, Vienna pp. 373-388